Association of interleukin-4 genetic polymorphisms with sporadic Alzheimer's disease in Chinese Han population

Neuroscience Letters

Volumn 563, Issue , 2014, Pages 17-21

  Li, Wei ^a   Qian, Xiaohua ^a   Teng, Hong ^a   Ding, Ying ^a   Zhang, Li ^a  

^a THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Han Chinese; IL 4; Linkage disequilibrium; Single nucleotide polymorphisms

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA; INTERLEUKIN 4; MOLECULAR MARKER;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHINESE HAN; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT; RISK ASSESSMENT;

ALZHEIMER'S DISEASE; HAN CHINESE; IL-4; LINKAGE DISEQUILIBRIUM; SINGLE NUCLEOTIDE POLYMORPHISMS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-4; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84893666756     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.019     Document Type: Article

References (37)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
3. Cooper N.R., Bradt B.M., O'Barr S., Yu J.X. Focal inflammation in the brain: role in Alzheimer's disease. Immunol. Res. 2000, 21:159-165.
4. Frazer M.E., Hughes J.E., Mastrangelo M.A., Tibbens J.L., Federoff H.J., Bowers W.J. Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4. Mol. Ther. 2008, 16:845-853.
5. Gadani S.P., Cronk J.C., Norris G.T., Kipnis J. IL-4 in the brain: a cytokine to remember. J. Immunol. 2012, 189:4213-4219.
6. Gambi F., Reale M., Iarlori C., Salone A., Toma L., Paladini C., De Luca G., Feliciani C., Salvatore M., Salerno R.M., Theoharides T.C., Conti P., Exton M., Gambi D. Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells. J. Clin. Psychopharm. 2004, 24:314-321.
7. Gervaziev Y.V., Kaznacheev V.A., Gervazieva V.B. Allelic polymorphisms in the interleukin-4 promoter regions and their association with bronchial asthma among the Russian population. Int. Arch. Allergy Immunol. 2006, 141:257-264.
8. Henkel G., Brown M.A. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc. Nat. Acad. Sci. USA 1994, 91:7737-7741.
9. Iribarren P., Chen K., Hu J., Zhang X., Gong W., Wang J.M. IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia. J. Immunol. 2005, 175:6100-6106.
10. Jin T., Li X., Zhang J., Wang H., Geng T., Li G., Gao G., Chen C. Genetic association between selected cytokine genes and glioblastoma in the Han Chinese population. BMC Cancer 2013, 13:236.
11. Karczewski K.J., Dudley J.T., Kukurba K.R., Chen R., Butte A.J., Montgomery S.B., Snyder M. Systematic functional regulatory assessment of disease-associated variants. Proc. Nat. Acad. Sci. USA 2013, 110:9607-9612.
12. Kawahara K., Suenobu M., Yoshida A., Koga K., Hyodo A., Ohtsuka H., Kuniyasu A., Tamamaki N., Sugimoto Y., Nakayama H. Intracerebral microinjection of interleukin-4/interleukin-13 reduces beta-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 2012, 207:243-260.
13. Kiyota T., Okuyama S., Swan R.J., Jacobsen M.T., Gendelman H.E., Ikezu T. CNS. expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J. 2010, 24:3093-3102.
14. Li Y., Guo B., Zhang L., Han J., Wu B., Xiong H. Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Resp. Med. 2008, 102:984-992.
15. Lugaresi A., Di Iorio A., Iarlori C., Reale M., De Luca G., Sparvieri E., Michetti A., Conti P., Gambi D., Abate G., Paganelli R. IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors. Exp. Gerontol. 2004, 39:653-657.
16. Luzina I.G., Keegan A.D., Heller N.M., Rook G.A., Shea-Donohue T., Atamas S.P. Regulation of inflammation by interleukin-4: a review of alternatives. J. Leukocyte Biol. 2012, 92:753-764.
17. Maher F.O., Nolan Y., Lynch M.A. Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol. Aging 2005, 26:717-728.
18. Noguchi E., Shibasaki M., Arinami T., Takeda K., Yokouchi Y., Kawashima T., Yanagi H., Matsui A., Hamaguchi H. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin. Exp. Allergy 1998, 28:449-453.
19. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993, 342:697-699.
20. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
21. Reale M., Iarlori C., Feliciani C., Gambi D. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. J. Alzheimer's Dis. 2008, 14:147-159.
22. Reale M., Iarlori C., Gambi F., Feliciani C., Isabella L., Gambi D. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Neuropharmacology 2006, 50:606-613.
23. Reale M., Iarlori C., Gambi F., Feliciani C., Salone A., Toma L., DeLuca G., Salvatore M., Conti P., Gambi D. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J. Neuroimmunol. 2004, 148:162-171.
24. Ribeiro de Almeida C., Heath H., Krpic S., Dingjan G.M., van Hamburg J.P., Bergen I., van de Nobelen S., Sleutels F., Grosveld F., Galjart N., Hendriks R.W. Critical role for the transcription regulator CCCTC-binding factor in the control of Th2 cytokine expression. J. Immunol. 2009, 182:999-1010.
25. Ribizzi G., Fiordoro S., Barocci S., Ferrari E., Megna M. Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol. Sci. 2010, 31:321-325.
26. Rosenwasser L.J., Klemm D.J., Dresback J.K., Inamura H., Mascali J.J., Klinnert M., Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy 1995, 25(Suppl 2):74-78. discussion 95-76.
27. Seet W.T., Mary Anne T.J., Yen T.S., Apolipoprotein E genotyping in the Malay, Chinese and Indian ethnic groups in Malaysia - a study on the distribution of the different apoE alleles and genotypes. Clin. Chim. Acta 2004, 340:201-205.
28. Shibata N., Ohnuma T., Takahashi T., Baba H., Ishizuka T., Ohtsuka M., Ueki A., Nagao M., Arai H. The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease. Neurosci. Lett. 2002, 323:161-163.
29. Shimizu E., Kawahara K., Kajizono M., Sawada M., Nakayama H. IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia. J. Immunol. 2008, 181:6503-6513.
30. Steinman L. Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 2008, 118:3557-3563.
31. Suzuki I., Hizawa N., Yamaguchi E., Kawakami Y. Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels. Clin. Exp. Allergy 2000, 30:1746-1749.
32. Szczepanik A.M., Funes S., Petko W., Ringheim G.E. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 2001, 113:49-62.
33. Takabayashi A., Ihara K., Sasaki Y., Kusuhara K., Nishima S., Hara T. Novel polymorphism in the 5'-untranslated region of the interleukin-4 gene. J. Human Genet. 1999, 44:352-353.
34. Wang M., Song H., Jia J. Interleukin-6 receptor gene polymorphisms were associated with sporadic Alzheimer's disease in Chinese Han. Brain Res. 2010, 1327:1-5.
35. Ward L.D., Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012, 40:D930-D934.
36. Xing X., Sha S., Li Y., Zong L., Jiang T., Cao Y. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation. J. Neurol. Sci. 2012, 313:17-21.
37. Zhenzhen L., Xianghua L., Qingwei W., Zhan G., Ning S. Three common polymorphisms in the IL-4 gene and cancer risk: a meta-analysis involving 5392 cases and 6,930 controls. Tumour Biol. 2013, 34:2215-2224.